Navigation Links
Catching the common cold virus genome
Date:3/16/2009

Catching the common cold virus: BYU researchers coming down with the rhinovirus genome

A new study by Brigham Young University researchers on the virus behind nearly half of all cold infections explains how and where evolution occurs in the rhinovirus genome and what this means for possible vaccines.

The study is reported in the April issue of the academic journal Molecular Biology and Evolution.

"There are a lot of different approaches to treating the cold, none of which seem to be effective," said Keith Crandall, professor of biology and co-author of the study. "This is partly because we haven't spent a lot of time studying the virus and its history to see how it's responding to the human immune system and drugs."

The BYU team studied genomic sequences available online and used computer algorithms to estimate how the rhinovirus is related to other viruses.

According to Nicole Lewis-Rogers, a postdoctoral fellow in the Biology Department and lead author on the study, the rhinovirus is similar to the polio virus, whose vaccine was announced in 1955. But while the polio virus has just three subspecies, the rhinovirus has more than 100 subspecies, which continually evolve.

"These viruses could be under the same constraints and yet change differently," Lewis-Rogers said. "That's why it is so hard to create a vaccine."

Through a computer program developed at BYU, Lewis-Rogers' team was able to identify the parts of the virus genome that enable resistance to drugs and the human immune system.

The immune system does a good job of recognizing viral contaminants and getting rid of them, as do new drugs, but the rhinovirus has responded to these defenses by changing its genome so that it is not so easily recognized.

"The virus is evolving solutions against the immune system and drugs," Crandall said. "The more we can learn about how the virus evolves solutions, the better we can rid the body of these infections."

Understanding where change occurs in the virus genome will help virologists who work to design drugs that target the rhinovirus.

"If you've got 10,000 bits of information, this narrows it down to a handful," Lewis-Rogers said. "Here is where you can start looking."

Lewis-Rogers and Crandall hope scientists will use these insights to build better drugs to combat the virus in the most effective way.


'/>"/>

Contact: Michael Smart
michael_smart@byu.edu
801-422-7320
Brigham Young University
Source:Eurekalert  

Related biology news :

1. Huntingtons disease: catching it early
2. Computer superpower strengthens attempts to combat common diseases
3. Common gene variants increase risk of hypertension, may lead to new therapies
4. New vaccine developed for preventing uncommon cold virus
5. Genetic testing not cost-effective in guiding initial dosing of common blood thinner
6. Common soil mineral degrades the nearly indestructible prion
7. Scientists uncover evolutionary keys to common birth disorders
8. Mayo Clinic: Brain disorder suggests common mechanism may underlie many neurodegenerative diseases
9. Common food additive found to increase risk and speed spread of lung cancer
10. Hairspray is linked to common genital birth defect, says study
11. GUMC researchers hone in on new strategy to treat common infection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Catching the common cold virus genome
(Date:1/12/2017)... research undertaken by Fit Small Business has revealed ... simply asked which office technology had they not used in ... Insights on what will be key features in ... industry leaders including Penelope Trunk , Martin Lindstrom ... Some of these findings included; ...
(Date:1/6/2017)... JOLLA, Calif. , Jan. 6, 2017 /PRNewswire/ ... 1 safety studies in healthy volunteers of a ... intended to treat acute pancreatitis. ... is typically a mild disorder, but can be ... organ failure and sepsis, where extended hospital stays, ...
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... sensor technology, today announced the launch of two ... systems, the highly-accurate biometric sensor modules that incorporate ... technology, experience and expertise. The two new designs ... specifically for hearables, and Benchmark BW2.0, a 2-LED ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... -- Aratana Therapeutics, Inc. (NASDAQ: PETX ), ... and commercialization of innovative biopharmaceutical products for companion animals, ... North America 2016. ... the FDA approval of three innovative therapeutics in 2016, ... oral solution) and NOCITA ® (bupivacaine liposome injectable ...
(Date:1/20/2017)... http://www.Financialbuzz.com - According ... causes of death worldwide. There were 8.2 million cancer ... related deaths increased gradually over time, the death rates ... various cancers continues to drive demand of biological therapies ... Market Insights, Inc. cancer biological therapy market size was USD ...
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
Breaking Biology Technology: